Loguercio, C., D'Argenio, G., Delle Cave, M., Cosenza, V., Della Valle, N., Mazzacca, G., & Del Vecchio Blanco, C
If you experience persistent vomiting or diarrhoea while taking GLP-1 medications, seek medical advice as this could lead to dehydration and electrolyte disturbances
Rapid weight loss can be associated with reductions in bone mineral density, which is of particular relevance to perimenopausal and postmenopausal women who are already at increased risk of osteoporosis
Administration is typically once daily, sometimes 5 days on/2 days off
We believe this portfolio offers the potential to reshape the treatment landscape, bring innovative products to patients and deliver attractive returns to our shareholders. Also in September, the European Medicines Agency approved Novo Nordisks oral semaglutide (Rybelsus), the first to reduce cardiovascular death, heart attack, and stroke, according to the companys website
Doctor Review - A licensed healthcare provider will review your medical information